Secondary analysis of RxPONDER (3102 women, node-positive HR+/HER2- breast cancer, RS ≤25): RS was similar by ethnicity, but proliferation scores were higher in Black and Hispanic women. IDFS was not significantly worse in Black women (HR 1.41); Asian women did better (HR 0.63).
Secondary analysisn = 3,102
Abdou et al. Recurrence Score gene group components and outcomes in the RxPONDER trial (SWOG S1007)